We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
UNLABELLED Acute myeloid leukemia (AML) describes a heterogenous group of hematological disorders. Cytogenetic and molecular assays have allowed patients' follow up aiming for detection of minimal residual disease, prediction of patients' outcome, in addition to providing the rationale for designing novel molecular-targeted therapeutic strategies. Human(More)
  • 1